Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma

Clinical trial NCT06961617 · RECRUITING

Trial details

NCT number: NCT06961617
Sponsor: Lion TCR Pte. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-06-01
Primary completion: 2027-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.